Grantopen🌐 United StatesRFA-FD-27-001
Research on Complex Generics
Food and Drug Administration
Description
The purpose of this funding opportunity is to expand access for Americans to high-quality, safe, and effective generic medicines, and help reduce the risk of drug shortages through a more competitive and multi-sourced generic drug market in the U.S., congruent with FDA’s Public Health Pillars.
Eligibility: Only the following applicant is eligible to apply for this single source funding: The University of Maryland
Award ceiling: 2,500,000
CFDA: 93.103
Details?
- Posted
- Nov 13, 2026
- Response deadline
- Dec 14, 2026, 5:00 AM UTC (30d)
- Type
- Grant
- Category
- 93.103
- Status
- open
- Buyer
- Food and Drug Administration
- Department
- HHS-FDA
- Jurisdiction
- United States
- Reference #
- RFA-FD-27-001
- Has Description
- true
- Doc Type
- synopsis
- Opp Status
- posted
Contact
Stephanie Bogan
Grantor
patrick.johnson@fda.hhs.govSimilar open opportunities
See opportunities like this one
GovBidAlerts matches this solicitation to similar open bids across 113,000+ open bids from 2,500+ sources. Create a free account to unlock them.
Create free accountno credit card required
This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.